Literature DB >> 12821618

Clinical course and management of SARS in health care workers in Toronto: a case series.

Monica Avendano1, Peter Derkach, Susan Swan.   

Abstract

BACKGROUND: Severe acute respiratory syndrome (SARS) has only recently been described. We provide individual patient data on the clinical course, treatment and complications experienced by 14 front-line health care workers and hospital support staff in Toronto who were diagnosed with SARS, and we provide follow-up information for up to 3 weeks after their discharge from hospital.
METHODS: As part of the initial response to the SARS outbreak in Toronto, our health care centre was asked to establish a SARS unit for health care workers who were infected. Patients were admitted to this unit and were closely monitored and treated until they were well enough to be discharged. We prospectively compiled information on their clinical course, management and complications and followed them for 3 weeks after discharge.
RESULTS: The 11 women and 3 men described here (mean age 42 [standard deviation [SD] 9] years) were all involved in providing medical or ancillary hospital services to patients who were later found to have SARS. Onset of symptoms in 4 of our patients who could clearly identify only a single contact with a patient with SARS occurred on average 4 (SD 3) days after exposure. For the remaining 10 patients with multiple patient contacts, symptom onset followed exposure by a mean of 3.5 (SD 3) days after their exposure. All patients were treated with ribavirin, and all patients received levofloxacin. Many experienced major complications. Dyspnea was present in 12 patients during their stay in hospital, and all developed abnormalities on chest radiograph; 3 patients developed severe hypoxemia (PaO(2) < 50 mm Hg). All patients experienced a drop in hemoglobin. Nine patients had hemolytic anemia. Three patients experienced numbness and tingling in their hands and feet, and 2 developed frank tetany. All 3 had magnesium levels that were less than 0.1 mmol/L. All patients recovered and were discharged home. At a follow-up examination 3 weeks after discharge (5 weeks after onset of illness), all patients were no longer weak but continued to become fatigued easily and had dyspnea on minimal exertion. For 5 patients, chest radiographs still showed residual disease.
INTERPRETATION: SARS is a very serious illness even in healthy, relatively young people. The clinical course in our patients, all of whom met the case definition for SARS (which requires pulmonary involvement), resulted in dyspnea and, in some individuals, severe hypoxemia. Severe hemolytic anemia may be a feature of SARS or may be a complication of therapy, possibly with ribavirin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821618      PMCID: PMC161610     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  13 in total

1.  Ribavirin in the treatment of SARS: A new trick for an old drug?

Authors:  Gideon Koren; Susan King; Sandra Knowles; Elizabeth Phillips
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

2.  Global surveillance for severe acute respiratory syndrome (SARS).

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2003-04-04

3.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

4.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

5.  A cluster of cases of severe acute respiratory syndrome in Hong Kong.

Authors:  Kenneth W Tsang; Pak L Ho; Gaik C Ooi; Wilson K Yee; Teresa Wang; Moira Chan-Yeung; Wah K Lam; Wing H Seto; Loretta Y Yam; Thomas M Cheung; Poon C Wong; Bing Lam; Mary S Ip; Jane Chan; Kwok Y Yuen; Kar N Lai
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

6.  Identification of severe acute respiratory syndrome in Canada.

Authors:  Susan M Poutanen; Donald E Low; Bonnie Henry; Sandy Finkelstein; David Rose; Karen Green; Raymond Tellier; Ryan Draker; Dena Adachi; Melissa Ayers; Adrienne K Chan; Danuta M Skowronski; Irving Salit; Andrew E Simor; Arthur S Slutsky; Patrick W Doyle; Mel Krajden; Martin Petric; Robert C Brunham; Allison J McGeer
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

7.  Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: case report.

Authors:  Moira Chan-Yeung; W C Yu
Journal:  BMJ       Date:  2003-04-19

Review 8.  Hypomagnesemic disorders.

Authors:  M J Dacey
Journal:  Crit Care Clin       Date:  2001-01       Impact factor: 3.598

9.  The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital.

Authors:  Robert Maunder; Jonathan Hunter; Leslie Vincent; Jocelyn Bennett; Nathalie Peladeau; Molyn Leszcz; Joel Sadavoy; Lieve M Verhaeghe; Rosalie Steinberg; Tony Mazzulli
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

10.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

View more
  51 in total

Review 1.  Antiviral treatment of SARS: can we draw any conclusions?

Authors:  Getu Zhaori
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

2.  SARS in health care workers.

Authors:  Gordon Farrow
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

3.  The psychological impact of SARS: a matter of heart and mind.

Authors:  Kang Sim; Hong Choon Chua
Journal:  CMAJ       Date:  2004-03-02       Impact factor: 8.262

4.  SARS transmission in Vietnam outside of the health-care setting.

Authors:  P A Tuan; P Horby; P N Dinh; L T Q Mai; M Zambon; J Shah; V Q Huy; S Bloom; R Gopal; J Comer; A Plant
Journal:  Epidemiol Infect       Date:  2006-07-26       Impact factor: 2.451

5.  Singapore's response to the severe acute respiratory syndrome outbreak: what do Singapore physicians think?

Authors:  Feng Qian; Meng Kin Lim
Journal:  Int J Public Health       Date:  2009-12-04       Impact factor: 3.380

6.  Controversies' clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages.

Authors:  George D Liatsos
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

7.  Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada.

Authors:  Monali Varia; Samantha Wilson; Shelly Sarwal; Allison McGeer; Effie Gournis; Eleni Galanis; Bonnie Henry
Journal:  CMAJ       Date:  2003-08-19       Impact factor: 8.262

8.  Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome.

Authors:  Mark J Cameron; Longsi Ran; Luoling Xu; Ali Danesh; Jesus F Bermejo-Martin; Cheryl M Cameron; Matthew P Muller; Wayne L Gold; Susan E Richardson; Susan M Poutanen; Barbara M Willey; Mark E DeVries; Yuan Fang; Charit Seneviratne; Steven E Bosinger; Desmond Persad; Peter Wilkinson; Larry D Greller; Roland Somogyi; Atul Humar; Shaf Keshavjee; Marie Louie; Mark B Loeb; James Brunton; Allison J McGeer; David J Kelvin
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

Review 9.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

10.  Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study.

Authors:  Harvey Moldofsky; John Patcai
Journal:  BMC Neurol       Date:  2011-03-24       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.